The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
 
Lisa Derosa
No Relationships to Disclose
 
Bertrand Routy
No Relationships to Disclose
 
David Enot
No Relationships to Disclose
 
Giulia Baciarello
No Relationships to Disclose
 
Christophe Massard
No Relationships to Disclose
 
Yohann Loriot
No Relationships to Disclose
 
Karim Fizazi
Honoraria - Astellas Pharma; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Curevac; ESSA; Janssen Oncology; Orion; Roche/Genentech; Sanofi
Travel, Accommodations, Expenses - Amgen
 
Bernard J. Escudier
No Relationships to Disclose
 
Laurence Zitvogel
Employment - EverImmune
Honoraria - Lytix Biopharma; Transgene; Transgene
Consulting or Advisory Role - Incyte; Lytix Biopharma
Research Funding - Lytix Biopharma; Roche; Roche; Transgene
Patents, Royalties, Other Intellectual Property - EverImmune has just been created and two patents have been licensed from my lab to EverImmune on microbial immunogenic effects in cancer therapeutics
 
Laurence Albiges
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Novartis; Pfizer; Sanofi
Research Funding - Novartis (Inst); Pfizer (Inst)